1. Kord-Varkaneh H, Salehi-Sahlabadi A, Tinsley GM, Santos HO, Hekmatdoost A. Effects of time-restricted feeding (16/8) combined with a low-sugar diet on the management of non-alcoholic fatty liver disease: a randomized controlled trial. Nutrition. 2023;105:111847. [ DOI:10.1016/j.nut.2022.111847] 2. Scorletti E, Bhatia L, McCormick KG, Clough GF, Nash K, Hodson L, et al. Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study. Hepatology. 2014;60(4):1211-21. [ DOI:10.1002/hep.27289] 3. Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. The lancet gastroenterology & hepatology. 2022;7(9):851-61. [ DOI:10.1016/S2468-1253(22)00165-0] 4. Kim D, Kim WR, Kim HJ, Therneau TM. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology. 2013;57(4):1357-65. [ DOI:10.1002/hep.26156] 5. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73-84. [ DOI:10.1002/hep.28431] 6. Karnikowski M, Córdova C, Oliveira RJd, Karnikowski MGdO, Nóbrega OdT. Non-alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adults. Sao Paulo Medical Journal. 2007;125:333-7. [ DOI:10.1590/S1516-31802007000600006] 7. Perez M, Gonzáles L, Olarte R, Rodríguez N, Tabares M, Salazar J, et al. Nonalcoholic fatty liver disease is associated with insulin resistance in a young Hispanic population. Preventive medicine. 2011;52(2):174-7. [ DOI:10.1016/j.ypmed.2010.11.021] 8. Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. The lancet Gastroenterology & hepatology. 2019;4(5):389-98. [ DOI:10.1016/S2468-1253(19)30039-1] 9. Zhou J, Zhou F, Wang W, Zhang XJ, Ji YX, Zhang P, et al. Epidemiological features of NAFLD from 1999 to 2018 in China. Hepatology. 2020;71(5):1851-64. [ DOI:10.1002/hep.31150] 10. James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018;392(10159):1789-858. [ DOI:10.1016/S0140-6736(18)32279-7] 11. Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. Journal of hepatology. 2023;79(2):516-37. [ DOI:10.1016/j.jhep.2023.03.017] 12. Saadati S, Sadeghi A, Mansour A, Yari Z, Poustchi H, Hedayati M, et al. Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial. BMC gastroenterology. 2019;19:1-6. [ DOI:10.1186/s12876-019-1055-4] 13. Hallsworth K, McPherson S, Anstee QM, Flynn D, Haigh L, Avery L. Digital intervention with lifestyle coach support to target dietary and physical activity behaviors of adults with nonalcoholic fatty liver disease: systematic development process of VITALISE using intervention mapping. Journal of Medical Internet Research. 2021;23(1):e20491. [ DOI:10.2196/20491] 14. Sullivan S, Kirk EP, Mittendorfer B, Patterson BW, Klein S. Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology. 2012;55(6):1738-45. [ DOI:10.1002/hep.25548] 15. Van Der Windt DJ, Sud V, Zhang H, Tsung A, Huang H. The effects of physical exercise on fatty liver disease. Gene expression. 2018;18(2):89. [ DOI:10.3727/105221617X15124844266408] 16. Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A, Gra-Oramas B, Gonzalez-Fabian L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149(2):367-78. e5. [ DOI:10.1053/j.gastro.2015.04.005] 17. Hallsworth K, Adams LA. Lifestyle modification in NAFLD/NASH: facts and figures. JHEP Reports. 2019;1(6):468-79. [ DOI:10.1016/j.jhepr.2019.10.008] 18. El-Agroudy NN, Kurzbach A, Rodionov RN, O'Sullivan J, Roden M, Birkenfeld AL, et al. Are lifestyle therapies effective for NAFLD treatment? Trends in Endocrinology & Metabolism. 2019;30(10):701-9. [ DOI:10.1016/j.tem.2019.07.013] 19. Moore MP, Cunningham RP, Dashek RJ, Mucinski JM, Rector RS. A fad too far? Dietary strategies for the prevention and treatment of NAFLD. Obesity. 2020;28(10):1843-52. [ DOI:10.1002/oby.22964] 20. Romero-Gómez M, Zelber-Sagi S, Trenell M. Treatment of NAFLD with diet, physical activity and exercise. Journal of hepatology. 2017;67(4):829-46. [ DOI:10.1016/j.jhep.2017.05.016] 21. Shojaee-Moradie F, Cuthbertson D, Barrett M, Jackson N, Herring R, Thomas E, et al. Exercise training reduces liver fat and increases rates of VLDL clearance but not VLDL production in NAFLD. The Journal of Clinical Endocrinology & Metabolism. 2016;101(11):4219-28. [ DOI:10.1210/jc.2016-2353] 22. Lazarus JV, Mark HE, Anstee QM, Arab JP, Batterham RL, Castera L, et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nature Reviews Gastroenterology & Hepatology. 2022;19(1):60-78. [ DOI:10.1038/s41575-021-00523-4] 23. Nassir F. NAFLD: mechanisms, treatments, and biomarkers. Biomolecules. 2022;12(6):824. [ DOI:10.3390/biom12060824] 24. Anania C, Perla FM, Olivero F, Pacifico L, Chiesa C. Mediterranean diet and nonalcoholic fatty liver disease. World journal of gastroenterology. 2018;24(19):2083. [ DOI:10.3748/wjg.v24.i19.2083] 25. Siavash M, Shokri S, Haghighi S, Shahtalebi MA, Farajzadehgan Z. The efficacy of topical royal jelly on healing of diabetic foot ulcers: a double‐blind placebo‐controlled clinical trial. International wound journal. 2015;12(2):137-42. [ DOI:10.1111/iwj.12063] 26. Tobin D, Brevik-Andersen M, Qin Y, Innes JK, Calder PC. Evaluation of a high concentrate omega-3 for correcting the omega-3 fatty acid nutritional deficiency in non-alcoholic fatty liver disease (CONDIN). Nutrients. 2018;10(8):1126. [ DOI:10.3390/nu10081126] 27. Bahrami M, Cheraghpour M, Jafarirad S, Alavinejad P, Asadi F, Hekmatdoost A, et al. The effect of melatonin on treatment of patients with non-alcoholic fatty liver disease: a randomized double blind clinical trial. Complementary therapies in medicine. 2020;52:102452. [ DOI:10.1016/j.ctim.2020.102452] 28. Aslan A, Cemek M, Buyukokuroglu ME, Altunbas K, Bas O, Yurumez Y. Royal jelly can diminish secondary neuronal damage after experimental spinal cord injury in rabbits. Food and chemical toxicology. 2012;50(7):2554-9. [ DOI:10.1016/j.fct.2012.04.018] 29. You MM, Liu YC, Chen YF, Pan YM, Miao ZN, Shi YZ, et al. Royal jelly attenuates nonalcoholic fatty liver disease by inhibiting oxidative stress and regulating the expression of circadian genes in ovariectomized rats. Journal of food biochemistry. 2020;44(3):e13138. [ DOI:10.1111/jfbc.13138] 30. Chiu H-F, Chen B-K, Lu Y-Y, Han Y-C, Shen Y-C, Venkatakrishnan K, et al. Hypocholesterolemic efficacy of royal jelly in healthy mild hypercholesterolemic adults. Pharmaceutical biology. 2017;55(1):497-502. [ DOI:10.1080/13880209.2016.1253110] 31. Lee PH, Macfarlane DJ, Lam TH, Stewart SM. Validity of the international physical activity questionnaire short form (IPAQ-SF): A systematic review. International journal of behavioral nutrition and physical activity. 2011;8:1-11. [ DOI:10.1186/1479-5868-8-115] 32. Yoneshiro T, Kaede R, Nagaya K, Aoyama J, Saito M, Okamatsu-Ogura Y, et al. Royal jelly ameliorates diet-induced obesity and glucose intolerance by promoting brown adipose tissue thermogenesis in mice. Obesity research & clinical practice. 2018;12(1):127-37. [ DOI:10.1016/j.orcp.2016.12.006] 33. Shiroma EJ, Lee I-M. Physical activity and cardiovascular health: lessons learned from epidemiological studies across age, gender, and race/ethnicity. Circulation. 2010;122(7):743-52. [ DOI:10.1161/CIRCULATIONAHA.109.914721] 34. Amirsasan R, Nikookheslat S, Dolgari R. Effect of eight weeks of pilates training on some physical fitness variables in untrained overweight females. Scientific Journal of Rehabilitation Medicine. 2017;6(1):192-200. 35. Hou K, Chen C, Wang X, Guo Y. Effects of emodin on blood glucose and body weight in type 1 diabetic rats. Universal Journal of Pharmaceutical Research. 2017. 36. Kocot J, Kiełczykowska M, Luchowska-Kocot D, Kurzepa J, Musik I. Antioxidant potential of propolis, bee pollen, and royal jelly: Possible medical application. Oxidative medicine and cellular longevity. 2018;2018(1):7074209. [ DOI:10.1155/2018/7074209] 37. Ghanbari E, Nejati V, Khazaei M. Improvement in serum biochemical alterations and oxidative stress of liver and pancreas following use of royal jelly in streptozotocin-induced diabetic rats. Cell Journal (Yakhteh). 2016;18(3):362. 38. Ghanbari E, Nejati V, Khazaei M. Antioxidant and protective effects of Royal jelly on histopathological changes in testis of diabetic rats. International Journal of Reproductive BioMedicine. 2016;14(8):519. [ DOI:10.29252/ijrm.14.8.519] 39. Pourfard H, Ahmadi A, Habibi Z, Asadi-Samani M, Shahinfard N, Soleimani A. The Effect of Tang Forte (Royal Jelly) Capsule on Hypoglycemia and Clinical Course in COVID-19 Patients Under Corticosteroid Therapy. Journal of Evidence-Based Integrative Medicine. 2023;28:2515690X231165333. [ DOI:10.1177/2515690X231165333] 40. He Z, Li X, Yang H, Wu P, Wang S, Cao D, et al. Effects of oral vitamin C supplementation on liver health and associated parameters in patients with non-alcoholic fatty liver disease: a randomized clinical trial. Frontiers in nutrition. 2021;8:745609. [ DOI:10.3389/fnut.2021.745609] 41. Zhang X, Lu X, Zhou Y, Guo X, Chang Y. Major royal jelly proteins prevents NAFLD by improving mitochondrial function and lipid accumulation through activating the AMPK/SIRT3 pathway in vitro. Journal of Food Science. 2021;86(3):1105-13. [ DOI:10.1111/1750-3841.15625] 42. Ghollpour Z, Nejati V, Najafi G, Karimpour Z, Khaneshi F. The protective effect of royal jelly on liver tissue of adult female rats with experimental polycystic ovarian syndrome. 2014. 43. Asgari M, Asle-Rousta M, Sofiabadi M. Effect of royal jelly on blood glucose and lipids in streptozotocin induced type 1 diabetic rats. Journal of Arak University of Medical Sciences. 2017;20(5):48-56. 44. Malekyian Fini E, Shavandi N, Saremi A. Effect of short-term Resvin supplementation on total antioxidant capacity ,super oxide dismutase, and creatine kinase in elite women volleyball players. Iranian Journal of Nutrition Sciences and Food Technology. 2013;8(3):79-86. 45. Marcell TJ, McAuley KA, Traustadóttir T, Reaven PD. Exercise training is not associated with improved levels of C-reactive protein or adiponectin. Metabolism. 2005;54(4):533-41. [ DOI:10.1016/j.metabol.2004.11.008] 46. Etemad Z, Zohali S. The effect of aerobic training and royal jelly supplementation on some inflammatory markers in overweight women. 2021.
|